ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS
申请人:Shin-Etsu Chemical Co., Ltd.
公开号:US20200223796A1
公开(公告)日:2020-07-16
A novel onium salt of formula (1) and a chemically amplified resist composition comprising the same as a PAG are provided. When processed by photolithography using KrF or ArF excimer laser, EB or EUV, the resist composition has a high sensitivity and reduced acid diffusion and is improved in exposure latitude, MEF, and LWR.
Trichlorotitanium and alkoxytitanium homoenolates. Preparation, characterization, and utilization for organic synthesis
作者:Eiichi. Nakamura、Hiroji. Oshino、Isao. Kuwajima
DOI:10.1021/ja00273a032
日期:1986.6
demi-equivalent d'alcoolate de titane (IV) sont plus reactives que I, fournissant des voies d'acces a des hydroxy-4 esters, γ-lactones et cyclopropanecarboxylates. Discussion du mecanisme de formation des homoenolates
Des eseses alcoxytitaniumgenerees par traitement de trichlorotitanio-3propionates d'alkyles (I) avec un demi-equivalent d'alcoolate de titane (IV) sont plus reactors que I, Fournissant des voies d'acces a des hydroxy-4esters, γ-内酯和环丙烷羧酸盐。同烯醇化物形成机制的讨论
PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY
申请人:Cannizzaro Carina
公开号:US20090227543A1
公开(公告)日:2009-09-10
The invention is related to phosphonate substituted compounds having immuno-modulatory activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
The invention is related to anti-viral phosphinate compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds
申请人:Cai R. Zhenhong
公开号:US20080076738A1
公开(公告)日:2008-03-27
Novel HIV integrase inhibitor compounds having at least one phosphonate group, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.